Gem Aromatics Ltd
Incorporated in October 1997, Gem Aromatics Limited manufactures speciality ingredients, including essential oils, aroma chemicals, and Value-Added Derivatives in India.[1]
- Market Cap ₹ 767 Cr.
- Current Price ₹ 147
- High / Low ₹ 350 / 133
- Stock P/E 536
- Book Value ₹ 86.1
- Dividend Yield 0.00 %
- ROCE 3.43 %
- ROE 0.39 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Promoter holding has increased by 1.95% over last quarter.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 3.68% over past five years.
- Company has a low return on equity of 12.6% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE IPO BSE Commodities Nifty IPO
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 306 | 314 | 425 | 452 | 504 | 366 | |
| 275 | 265 | 359 | 374 | 416 | 326 | |
| Operating Profit | 31 | 49 | 66 | 78 | 88 | 41 |
| OPM % | 10% | 16% | 16% | 17% | 18% | 11% |
| 4 | 3 | 0 | 2 | 2 | 1 | |
| Interest | 2 | 3 | 6 | 6 | 8 | 13 |
| Depreciation | 3 | 4 | 5 | 6 | 7 | 23 |
| Profit before tax | 30 | 44 | 56 | 68 | 75 | 6 |
| Tax % | 23% | 30% | 20% | 26% | 29% | 78% |
| 23 | 31 | 45 | 50 | 53 | 1 | |
| EPS in Rs | 129.92 | 174.74 | 250.27 | 10.69 | 11.39 | 0.27 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 4% |
| 3 Years: | -5% |
| TTM: | -27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -43% |
| 3 Years: | -68% |
| TTM: | -97% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 16% |
| 3 Years: | 13% |
| Last Year: | 0% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 9 | 9 | 10 |
| Reserves | 108 | 136 | 178 | 221 | 275 | 439 |
| 55 | 78 | 90 | 112 | 225 | 152 | |
| 20 | 23 | 26 | 26 | 26 | 40 | |
| Total Liabilities | 186 | 240 | 296 | 369 | 535 | 642 |
| 24 | 36 | 36 | 50 | 54 | 253 | |
| CWIP | 2 | 1 | 11 | 30 | 126 | 6 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| 160 | 203 | 249 | 289 | 355 | 382 | |
| Total Assets | 186 | 240 | 296 | 369 | 535 | 642 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| -0 | -5 | 15 | 40 | -25 | 30 | |
| -5 | -15 | -18 | -50 | -92 | -101 | |
| 7 | 18 | 6 | 15 | 103 | 78 | |
| Net Cash Flow | 2 | -2 | 4 | 5 | -15 | 6 |
| Free Cash Flow | -6 | -19 | 1 | 1 | -130 | -65 |
| CFO/OP | 24% | 12% | 50% | 71% | 1% | 100% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 63 | 46 | 68 | 37 | 102 | 76 |
| Inventory Days | 120 | 206 | 164 | 187 | 161 | 309 |
| Days Payable | 23 | 27 | 24 | 20 | 23 | 25 |
| Cash Conversion Cycle | 160 | 225 | 208 | 203 | 241 | 360 |
| Working Capital Days | 90 | 110 | 102 | 121 | 116 | 179 |
| ROCE % | 25% | 25% | 24% | 19% | 3% |
Insights
In beta| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Actual Production Volume MT |
|
||||
| Installed Production Capacity MTPA |
|||||
| Repeat Customers Revenue Contribution % |
|||||
| Total Number of Customers Number |
|||||
| Market Share - Clove Oil (India) % |
|||||
| Market Share - Eucalyptus Oil (India) % |
|||||
| Market Share - Eugenol (India) % |
|||||
| Number of Products in Portfolio Number |
|||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
26 May - Q4/FY26 investor call transcript filed; Dahej commercial production began, ₹270 crore capex and FY28 guidance discussed.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
22 May - Audio recording of Q4 and FY26 investor conference call held on 22 May 2026 uploaded online.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 22 May
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
21 May - Gem Aromatics reported Q4FY26 and FY26 results; Dahej capex ~Rs260 Cr, EcoVadis Platinum, new production began 26 Feb 2026.
- Announcement under Regulation 30 (LODR)-Investor Presentation 21 May
Concalls
-
May 2026Transcript PPT
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT REC
Business Profile[1][2]
The company specializes in producing high-quality essential oils, aroma chemicals, and value-added derivatives. It has a strong foundation in mint- and clove-based products and growing capabilities in eucalyptus and phenol derivatives, it offers a portfolio of around 70 products across four categories. These ingredients find wide applications in oral care, cosmetics, nutraceuticals, pharmaceuticals, wellness and pain management, as well as personal care segments.